Jeff joined LifeArc in 2010 and is the Director of Preclinical Science. He is a biologist, neuroscientist, and pharmacologist who has led and supported early-phase preclinical drug discovery for more than 35 years. With a background in the pharmaceutical industry and now in his current role at LifeArc, Jeff and his teams have worked across multiple therapeutic areas and target classes, most notably GPCRs and ion channels, spanning small molecules, therapeutic antibodies, and novel modalities.
His programmes have ranged in maturity from early discovery and target validation through to candidate selection and out-licensing. In keeping with LifeArc’s collaborative ethos, Jeff’s work spans industry, biotechnology, academia, charities, and research institutions, bringing together diverse multidisciplinary expertise to advance innovative healthcare solutions.
